Patents by Inventor Heng GE

Heng GE has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Control method and device of energy-storage coordinated floating wind turbine
    Patent number: 11959455
    Abstract: Provided are control method and device of an energy-storage coordinated floating wind turbine, relating to the technical field of wind turbines. The control method of an energy-storage coordinated floating wind turbine can construct a primary frequency regulation model of a floating wind farm based on a frequency response unit, construct a second frequency regulation model according to an energy storage system, further construct, according to the primary frequency regulation model and the second frequency regulation model, a frequency regulation model of a hybrid power system containing the floating wind farm, the energy storage system, and a pre-set thermal power unit, and design an overall frequency regulation control strategy of the hybrid power system based on the frequency regulation model of the hybrid power system.
    Type: Grant
    Filed: April 6, 2023
    Date of Patent: April 16, 2024
    Assignees: NORTH CHINA ELECTRIC POWER UNIVERSITY, HUANENG GROUP R &D CENTER CO LTD
    Inventors: Yang Hu, Ziqiu Song, Fang Fang, Jizhen Liu, Xiaojiang Guo, Qinghua Wang, Heng Ge
  • NEW CRYSTALLINE FORMS OF A KRAS G12C INHIBITOR COMPOUND
    Publication number: 20240116900
    Abstract: Provided are crystalline forms of a KRAS G12C inhibitor compound and to processes for their preparation. Furthermore, provided is pharmaceutical composition comprising said crystalline forms, and at least one pharmaceutically acceptable excipient. The pharmaceutical composition can be used as a medicament, in particular for the treatment of cancer, and KRAS G12C-mutant cancer.
    Type: Application
    Filed: October 29, 2021
    Publication date: April 11, 2024
    Inventors: Simona COTESTA, Heng GE, Marc GERSPACHER, Catherine LEBLANC, Bo LIU, Edwige Liliane Jeanne LORTHIOIS, Rainer MACHAUER, Robert MAH, Tanja MEISTER, Christophe MURA, Pascal RIGOLLIER, Nadine SCHNEIDER, Stefan STUTZ, Andrea VAUPEL, Nicolas WARIN, Rainer WILCKEN, Lijun XUE, Marie-Anne LOZAC'H, Ross STRANG
  • NAPHTHYRIDINONE DERIVATIVES FOR THE TREATMENT OF A DISEASE OR DISORDER
    Publication number: 20230203032
    Abstract: The invention relates to a compound of formula (I): or a pharmaceutically acceptable salt thereof, wherein A, R1 and R3 are as described herein, as well as compositions and methods of using such compounds.
    Type: Application
    Filed: November 21, 2022
    Publication date: June 29, 2023
    Inventors: Atwood Kim CHEUNG, Donglei LIU, Stefan PEUKERT, Heng GE, Yu GAI, Xingjuan CHANG
  • Crystalline form I of ibrutinib
    Patent number: 9751889
    Abstract: Crystalline Form I of ibrutinib, processes for its preparation, pharmaceutical compositions comprising the new Form, and use of Form I of ibrutinib for treating or delaying diseases or disorders related to activity of Bruton's tyrosine kinase (BTK) proteins are disclosed. The novel Form was characterized by X-ray powder diffraction, differential scanning calorimetry, and other techniques. It can be readily prepared and is suitable for use in the preparation of solid dosage forms.
    Type: Grant
    Filed: November 26, 2014
    Date of Patent: September 5, 2017
    Assignees: Crystal Pharmatech Inc., Suzhou Pengxu Pharmatech Co., Ltd.
    Inventors: Minhua Chen, Yanfeng Zhang, Chaohui Yang, Xiaoyu Zhang, Peng Wang, Pixu Li, Fei Lu, Heng Ge
  • CRYSTALLINE FORM I OF IBRUTINIB
    Publication number: 20170002009
    Abstract: Crystalline Form I of ibrutinib, processes for its preparation, pharmaceutical compositions comprising the new Form, and use of Form I of ibrutinib for treating or delaying diseases or disorders related to activity of Bruton's tyrosine kinase (BTK) proteins are disclosed. The novel Form was characterized by X-ray powder diffraction, differential scanning calorimetry, and other techniques. It can be readily prepared and is suitable for use in the preparation of solid dosage forms.
    Type: Application
    Filed: November 26, 2014
    Publication date: January 5, 2017
    Applicants: CRYSTAL PHARMATECH INC., SUZHOU PENGXU PHARMATECH CO., LTD.
    Inventors: Minhua CHEN, Yanfeng ZHANG, Chaohui YANG, Xiaoyu ZHANG, Peng WANG, Pixu LI, Fei LU, Heng GE